`
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`MYLAN PHARMACEUTICALS INC.,
`MSN LABORATORIES PRIVATE LTD.,
`and MSN PHARMACEUTICALS INC.,
`Petitioners,
`
`v.
`
`BAUSCH HEALTH IRELAND LIMITED,
`Patent Owner.
`
`————————————————
`Case IPR2022-007221
`Patent 7,041,786
`————————————————
`
`NOTICE OF DEPOSITION OF
`SCOTT A. WALDMAN, M.D., PH.D., FDP, FAHA, FNAL FASPET
`
`1 IPR2023-00016 has been joined with this proceeding.
`
`
`
`Case IPR2022-00722
`Patent No. 7,041,786
`
`Pursuant to 37 C.F.R. § 42.53, Mylan Pharmaceuticals Inc., by and through
`
`its attorneys, will conduct examination by deposition of Scott A Waldman M.D.,
`
`Ph.D., FDP, FAHA, FNAL FASPET, in the above-referenced proceeding. The
`
`deposition will commence at 9:00 AM (local time) on March 8, 2023, at the
`
`Washington, D.C. offices of Finnegan, Henderson, Farabow, Garrett & Dunner,
`
`901 New York Avenue, N.W., Washington, DC 20001 The deposition will be
`
`taken before a Notary Public or other officer authorized by law to administer oaths
`
`and will be recorded by stenographic and/or audio-visual means. The
`
`arrangements for the reporter will be made by counsel for Mylan Pharmaceuticals
`
`Inc.
`
`Dated: February 13, 2023
`
`Respectfully submitted,
`/Jad A. Mills/
`Jad A. Mills, Reg. No. 63,344
`Counsel for Mylan Pharmaceuticals Inc.
`
`-1-
`
`
`
`Case IPR2022-00722
`Patent No. 7,041,786
`
`CERTIFICATE OF SERVICE
`
`I certify that Petitioners’ Notice of Deposition of Dr. Scott A. Waldman was
`
`served today on the electronic service addresses of the Patent Owner specified as
`
`follows:
`
`Justin J. Hasford
`
`justin.hasford@finnegan.com
`
`Bryan C. Diner
`
`bryan.diner@finnegan.com
`
`Joshua Goldberg
`
`joshua.goldberg@finnegan.com
`
`Caitlin O’Connell
`
`caitlin.o’connell@finnegan.com
`
`Kyu Yun Kim
`
`kyuyun.kim@finnegan.com
`
`Kassandra Officer
`
`kassandra.officer@finnegan.com
`
`and on MSN’s counsel at:
`
`Andrew Larsen
`
`alarsen@merchantgould.com
`
`Melissa Hayworth
`
`mhayworth@merchantgould.com
`
`Dated: February 13, 2023
`
`Respectfully submitted,
`/Robyn Moriarty/
`Robyn Moriarty
`
`-2-
`
`